Molecular Mechanisms of Aminoglycoside Ototoxicity
氨基糖苷类耳毒性的分子机制
基本信息
- 批准号:10443277
- 负责人:
- 金额:$ 56.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-07 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:Adverse effectsAdverse reactionsAffectAminoglycosidesAntibioticsAntibodiesAreaBindingBinding ProteinsBiochemicalBiochemistryBiological AssayCell DeathCell SurvivalCell physiologyClinicalCochleaDataDevelopmentDyesGenesGeneticGentamicinsGoalsHairHair CellsHumanImmunoblot AnalysisImmunofluorescence ImmunologicInfectionKnockout MiceLabelLabyrinthLifeLinkMass Spectrum AnalysisMediatingMethodsMitochondriaMolecularMorphogenesisMulti-Drug ResistanceMusMutationNamesOrganismPINK1 geneParkinPathologicPathway interactionsPharmacologyPhysiological ProcessesPreventionProductionProteinsReactive Oxygen SpeciesResearchRoleSensory ReceptorsSignal PathwayStainsTestingYeastsaminoglycoside-induced ototoxicitybasehearing impairmentin vivoinsightlink proteinlive cell imagingmechanotransductionmouse modelnew therapeutic targetnormal hearingnovelnovel strategiesototoxicitypermanent hearing losspreventprotein functionresponsescreeningtherapeutic developmentyeast two hybrid system
项目摘要
PROJECT SUMMARY
Aminoglycosides are widely used to treat serious infections, as they have good activity against many multi-
drug resistant Gram-negative organisms. However, their strong and irreversible ototoxicity significantly limits
their clinical usage. The overall goal of this research is to investigate the pathological mechanisms underlying
AG ototoxicity and provide novel therapeutic targets to prevent it. We propose to investigate the functions of
aminoglycoside-binding proteins in hair cells, the sensory receptors in the inner ear. In our preliminary studies,
we have identified several proteins essential for aminoglycoside ototoxicity. Based on our preliminary data, we
hypothesize that a novel pathological mechanism is involved in aminoglycoside ototoxicity. To test our
hypothesis, we will: i) continue to investigate the expression, localization and functions of these proteins in hair
cells; ii) continue to characterize mouse lines carrying mutations in these genes; iii) continue to investigate the
functional interactions of these proteins in aminoglycoside ototoxicity. Our preliminary data show the feasibility
of our approach. We anticipate that our studies will shed new insights into the molecular mechanisms
underlying aminoglycoside ototoxicity and provide new leads for the development of new approaches to
prevent aminoglycoside-induced hearing loss.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bo Zhao其他文献
Bo Zhao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bo Zhao', 18)}}的其他基金
Molecular Mechanisms of Aminoglycoside Ototoxicity
氨基糖苷类耳毒性的分子机制
- 批准号:
10569609 - 财政年份:2022
- 资助金额:
$ 56.87万 - 项目类别:
Optimized MR Fingerprinting for Rapid Volumetric Quantitative Neuroimaging
用于快速体积定量神经成像的优化 MR 指纹识别
- 批准号:
10266853 - 财政年份:2020
- 资助金额:
$ 56.87万 - 项目类别:
Optimized MR Fingerprinting for Rapid Volumetric Quantitative Neuroimaging
用于快速体积定量神经成像的优化 MR 指纹识别
- 批准号:
10450170 - 财政年份:2020
- 资助金额:
$ 56.87万 - 项目类别:
Optimized MR Fingerprinting for Rapid Volumetric Quantitative Neuroimaging
用于快速体积定量神经成像的优化 MR 指纹识别
- 批准号:
10260805 - 财政年份:2020
- 资助金额:
$ 56.87万 - 项目类别:
Functions of Fam65b protein complex at the basal stereocilia in hearing and deafness
基底静纤毛 Fam65b 蛋白复合物在听力和耳聋中的功能
- 批准号:
10194456 - 财政年份:2018
- 资助金额:
$ 56.87万 - 项目类别:
Functions of Fam65b protein complex at the basal stereocilia in hearing and deafness
基底静纤毛 Fam65b 蛋白复合物在听力和耳聋中的功能
- 批准号:
10433855 - 财政年份:2018
- 资助金额:
$ 56.87万 - 项目类别:
Targeting Epstein-Barr Virus Super-Enhancer
针对 Epstein-Barr 病毒超级增强子
- 批准号:
9970995 - 财政年份:2016
- 资助金额:
$ 56.87万 - 项目类别:
Targeting Epstein-Barr Virus Super-Enhancer
靶向 Epstein-Barr 病毒超级增强子
- 批准号:
10379876 - 财政年份:2016
- 资助金额:
$ 56.87万 - 项目类别:
Targeting Epstein-Barr Virus Super-Enhancer
靶向 Epstein-Barr 病毒超级增强子
- 批准号:
10596159 - 财政年份:2016
- 资助金额:
$ 56.87万 - 项目类别:
相似海外基金
A personalised approach to manage adverse reactions to CFTR modulator therapy in patients with cystic fibrosis
治疗囊性纤维化患者 CFTR 调节剂治疗不良反应的个性化方法
- 批准号:
MR/X00094X/1 - 财政年份:2022
- 资助金额:
$ 56.87万 - 项目类别:
Research Grant
Identifying genetic polymorphisms and elucidating polygenic architecture associated with adverse reactions due to rituximab
识别遗传多态性并阐明与利妥昔单抗不良反应相关的多基因结构
- 批准号:
22K15910 - 财政年份:2022
- 资助金额:
$ 56.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanistic study of sulfa drug-induced severe cutaneous adverse reactions by focusing on HLA-A*11:01
以HLA-A*为重点的磺胺类药物致严重皮肤不良反应机制研究11:01
- 批准号:
22K06738 - 财政年份:2022
- 资助金额:
$ 56.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Severe Cutaneous Adverse Reactions Following Outpatient Antibiotic Therapy: A Population-based Study
门诊抗生素治疗后的严重皮肤不良反应:一项基于人群的研究
- 批准号:
449379 - 财政年份:2020
- 资助金额:
$ 56.87万 - 项目类别:
Studentship Programs
Significance of gamma-chain in severe cutaneous adverse reactions
伽马链在严重皮肤不良反应中的意义
- 批准号:
19K17779 - 财政年份:2019
- 资助金额:
$ 56.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Historical sociology of adverse reactions related to vaccination in Japan
日本疫苗接种不良反应的历史社会学
- 批准号:
18K00267 - 财政年份:2018
- 资助金额:
$ 56.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SEARCH (active Surveillance and Evaluation of Adverse Reactions in Canadian Healthcare) & PREVENT (Pharmacogenomics of Adverse Reaction EVEnts National Team)
SEARCH(加拿大医疗保健不良反应的主动监测和评估)
- 批准号:
379425 - 财政年份:2018
- 资助金额:
$ 56.87万 - 项目类别:
Operating Grants
IGF::OT::IGF SBIR Phase II: Topic 338 - Predictive Biomarkers of Adverse Reactions to Prostrate Cancer Radiotherapy
IGF::OT::IGF SBIR II 期:主题 338 - 前列腺癌放射治疗不良反应的预测生物标志物
- 批准号:
9576448 - 财政年份:2017
- 资助金额:
$ 56.87万 - 项目类别:
Development of in silico prediction method for idiosyncratic adverse reactions associated with HLA genotypes
与 HLA 基因型相关的特殊不良反应的计算机预测方法的开发
- 批准号:
16K15156 - 财政年份:2016
- 资助金额:
$ 56.87万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Characterising the Immune Response to Drugs That Cause Idiosyncratic Adverse Reactions
表征对引起特殊不良反应的药物的免疫反应
- 批准号:
367156 - 财政年份:2016
- 资助金额:
$ 56.87万 - 项目类别:
Studentship Programs














{{item.name}}会员




